PTP
PHAS
Platform Technology Partners’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-231,900
| Closed | -$41K | – | 215 |
|
|
2022
Q3 | $41K | Sell |
231,900
-11,000
| -5% | -$1.95K | 0.02% | 184 |
|
|
2022
Q2 | $146K | Buy |
242,900
+427
| +0.2% | +$257 | 0.08% | 173 |
|
|
2022
Q1 | $320K | Sell |
242,473
-9,250
| -4% | -$12.2K | 0.15% | 143 |
|
|
2021
Q4 | $657K | Buy |
251,723
+22,500
| +10% | +$58.7K | 0.29% | 88 |
|
|
2021
Q3 | $713K | Sell |
229,223
-150
| -0.1% | -$467 | 0.32% | 82 |
|
|
2021
Q2 | $853K | Buy |
+229,373
| New | +$853K | 0.35% | 81 |
|
|
2020
Q4 | $474K | Buy |
141,025
+48,075
| +52% | +$162K | 0.23% | 115 |
|
|
2020
Q3 | $326K | Buy |
92,950
+38,976
| +72% | +$137K | 0.2% | 126 |
|
|
2020
Q2 | $248K | Buy |
53,974
+19,224
| +55% | +$88.3K | 0.17% | 143 |
|
|
2020
Q1 | $115K | Buy |
+34,750
| New | +$115K | 0.1% | 155 |
|